Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 9/20 | 0.71 |
| ▸ | MAOA | P21397 | 8/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.71 |
| ▸ | HPGD | P15428 | 5/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.71 |
| ▸ | NPC1 | O15118 | 4/20 | 0.71 |
| ▸ | RAB9A | P51151 | 4/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.71 |
| ▸ | ALDH2 | P05091 | 4/20 | 0.71 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.71 |
| ▸ | TP53 | P04637 | 3/20 | 0.71 |
| ▸ | MAPT | P10636 | 3/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.71 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | TTR | P02766 | 2/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isoflavone SCHEMBL28075346 | 0.92 | ALDH1A1 (0.70) | MAOBMAOAALDH1A1SMN1; SMN2HPGD | |
| Daidzein SCHEMBL2025991 | 0.90 | KDM4E (0.86) | MAOBMAOAALDH1A1SMN1; SMN2HPGD | |
| Isoflavone SCHEMBL3066716 | 0.88 | ALOX12 (0.80) | MAOBMAOAALDH1A1SMN1; SMN2HPGD | |
| Daidzein SCHEMBL28743634 | 0.87 | KDM4E (0.76) | MAOBMAOAALDH1A1SMN1; SMN2HPGD | |
| Isoflavone SCHEMBL8028 | 0.86 | ALDH1A1 (0.66) | MAOBMAOAALDH1A1SMN1; SMN2HPGD | |
| Isoflavone SCHEMBL6542422 | 0.86 | ALDH1A1 (0.66) | MAOBMAOAALDH1A1SMN1; SMN2HPGD | |
| Isoflavone SCHEMBL6290885 | 0.86 | ALDH1A1 (0.66) | MAOBMAOAALDH1A1SMN1; SMN2HPGD | |
| Isoflavone SCHEMBL31264756 | 0.86 | ALDH1A1 (0.66) | MAOBMAOAALDH1A1SMN1; SMN2HPGD | |
| Isoflavone SCHEMBL27523008 | 0.85 | ALDH1A1 (0.65) | MAOBMAOAALDH1A1SMN1; SMN2HPGD | |
| Isoflavone SCHEMBL4941824 | 0.84 | ALOX15 (0.76) | MAOBMAOAALDH1A1SMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-60048924-A | — | — | None | — | — | JP | disclosed |
| US-20230330059-A1 | 3-PHENYL-2H-CHROMENE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S, CONTAINING SAME | NEUROBIONET, INC. (KR) | 2023-10-19 | — | — | US | disclosed |
| CN-106061476-B | Use of isoflavones for treating retroviral infections | 港大科桥有限公司 | 2021-06-08 | — | — | CN | disclosed |
| EP-3082799-B1 | USE OF ISOFLAVONES FOR THE TREATMENT OF RETROVIRAL INFECTION | VERSITECH LTD (CN) | 2021-04-28 | — | — | EP | disclosed |
| EP-3082799-A1 | USE OF ISOFLAVONES FOR THE TREATMENT OF RETROVIRAL INFECTION | Versitech Limited (CN) | 2016-10-26 | — | — | EP | disclosed |
| WO-2015090201-A1 | USE OF ISOFLAVONES FOR THE TREATMENT OF RETROVIRAL INFECTION | VERSITECH LIMITED (CN) | 2015-06-25 | — | — | WO | disclosed |
| US-8742141-B2 | Inhibition and treatment of prostate cancer metastasis | NORTHWESTERN UNIVERSITY (US) | 2014-06-03 | — | — | US | disclosed |
| US-8742141-B2 | Inhibition and treatment of prostate cancer metastasis | NORTHWESTERN UNIVERSITY (US) | 2014-06-03 | — | — | US | disclosed |
| US-20130296582-A1 | INHIBITION AND TREATMENT OF PROSTATE CANCER METASTASIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-11-07 | — | — | US | disclosed |
| US-20130296582-A1 | INHIBITION AND TREATMENT OF PROSTATE CANCER METASTASIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-11-07 | — | — | US | disclosed |
| US-20080207610-A1 | ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION | AMYGDALA NEUROSCIENCES, INC. | 2008-08-28 | — | — | US | disclosed |
| US-7368434-B2 | Compounds useful for the inhibition of ALDH | THE ENDOWMENT FOR RESEARCH IN HUMAN BIOLOGY, INC. (US) | 2008-05-06 | — | — | US | disclosed |
| US-20080032995-A1 | ALDH-2 INHIBITORS IN THE TREATMENT OF DRUG ADDICTION | AMYGDALA NEUROSCIENCES, INC. | 2008-02-07 | — | — | US | disclosed |
| EP-1838296-A2 | FLAVANOIDS AND ISOFLAVANOIDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES | RESVERLOGIX CORP. (CA) | 2007-10-03 | — | — | EP | disclosed |
| US-20060205767-A1 | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases | HEPALINK (HONG KONG) LIMITED (HK) | 2006-09-14 | — | — | US | disclosed |
| WO-2006045096-A2 | FLAVANOIDS AND ISOFLAVANOIDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES | RESVERLOGIX CORP. (CA) | 2006-04-27 | — | — | WO | disclosed |
| EP-1542675-A1 | COMPOUNDS USEFUL FOR THE INHIBITION OF ALDH | The Endowment For Research In Human Biology, Inc. (US) | 2005-06-22 | — | — | EP | disclosed |
| US-20040068003-A1 | Compounds useful for the inhibition of ALDH | THE ENDOWMENT FOR RESEARCH IN HUMAN BIOLOGY, INC, | 2004-04-08 | — | — | US | disclosed |
| WO-2004002470-A1 | COMPOUNDS USEFUL FOR THE INHIBITION OF ALDH | THE ENDOWMENT FOR RESEARCH IN HUMAN BIOLOGY, INC. (US) | 2004-01-08 | — | — | WO | disclosed |
| JP-S6048924-A | REMEDY FOR OSTEOPOROSIS | TAKEDA CHEM IND LTD | 1985-03-16 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060205767-A1 | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases | APOB, APOL1, FABP3 | MAOB 385/4885MAOA 251/4885ALDH1A1 1211/4885 |
| US-20130296582-A1 | INHIBITION AND TREATMENT OF PROSTATE CANCER METASTASIS | MAPK4, MAP4K4, MAP3K4 | MAOB 2694/4885MAOA 2714/4885ALDH1A1 1204/4885 |
| US-20080207610-A1 | ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION | ALDH1A1, ADH1A, ALDH3A1 | MAOB 47/4885MAOA 62/4885ALDH1A1 1/4885 |
| US-20230330059-A1 | 3-PHENYL-2H-CHROMENE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S, CONTAINING SAME | APP, BACE1, MAPT | MAOB 1168/4885MAOA 492/4885ALDH1A1 1317/4885 |
| US-20040068003-A1 | Compounds useful for the inhibition of ALDH | ALDH2, ALDH1A1, ALDH3A1 | MAOB 399/4885MAOA 484/4885ALDH1A1 2/4885 |
| US-20080032995-A1 | ALDH-2 INHIBITORS IN THE TREATMENT OF DRUG ADDICTION | ALDH1A1, ADH1A, ALDH3A1 | MAOB 45/4885MAOA 62/4885ALDH1A1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.